MO-0556 Reduction of the CTV margin in glioblastoma leads to dosimetric benefit without compromising outcome. - Di Perri, D.; Hartgerink, D.; Terhaag, K.; Houben, R.; Compter, I.; Eekers, D. (Radiotherapy & Oncology, 2023)